Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             74 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Advances in genomic characterization of circulating tumor cells Magbanua, Mark Jesus M.
2014
2-3 p. 757-769
artikel
2 A multi-targeted approach to treating bone metastases Camacho, Daniel F.
2014
2-3 p. 545-553
artikel
3 Androgen receptor signaling in prostate cancer Culig, Zoran
2014
2-3 p. 413-427
artikel
4 Angiogenesis and vascular stability in eicosanoids and cancer Hu, Jiong
2018
2-3 p. 425-438
artikel
5 Antibody-based imaging strategies for cancer Warram, Jason M.
2014
2-3 p. 809-822
artikel
6 AR function in promoting metastatic prostate cancer Augello, Michael A.
2014
2-3 p. 399-411
artikel
7 Bioactive lipid metabolism in platelet “first responder” and cancer biology Kanikarla-Marie, Preeti
2018
2-3 p. 439-454
artikel
8 Bioanalytical insights into the association between eicosanoids and pathogenesis of hepatocellular carcinoma Xu, Yong-Jiang
2018
2-3 p. 269-277
artikel
9 Biographies 2018
2-3 p. 199-200
artikel
10 Biography—Elisabeth I. Heath, MD FACP 2014
2-3 p. 373
artikel
11 Bone marrow fat: linking adipocyte-induced inflammation with skeletal metastases Hardaway, Aimalie L.
2014
2-3 p. 527-543
artikel
12 Bone-targeting agents in prostate cancer Suzman, Daniel L.
2014
2-3 p. 619-628
artikel
13 Cell surface association of matrix metalloproteinase-9 (gelatinase B) Fridman, Rafael
2003
2-3 p. 153-166
artikel
14 Circulating tumour cells—a bona fide cause of metastatic cancer Caixeiro, N. J.
2014
2-3 p. 747-756
artikel
15 Clinical models and biochemical predictors of VTE in lung cancer Roselli, M.
2014
2-3 p. 771-789
artikel
16 Eicosanoids and HB-EGF/EGFR in cancer Yang, Cheng-Chieh
2018
2-3 p. 385-395
artikel
17 Eicosanoid signaling in carcinogenesis of colorectal cancer Wang, Yuxin
2018
2-3 p. 257-267
artikel
18 Eicosanoids in prostate cancer Panagiotopoulos, Athanassios A.
2018
2-3 p. 237-243
artikel
19 Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy Chang, Lei
2014
2-3 p. 469-496
artikel
20 Emerging strategies to overcome resistance to endocrine therapy for breast cancer Ziauddin, M. Firdos
2014
2-3 p. 791-807
artikel
21 Emerging technology: applications of Raman spectroscopy for prostate cancer Kast, Rachel E.
2014
2-3 p. 673-693
artikel
22 Evaluation of oncogenic cysteinyl leukotriene receptor 2 as a therapeutic target for uveal melanoma Slater, K.
2018
2-3 p. 335-345
artikel
23 Extracellular acidity, a “reappreciated” trait of tumor environment driving malignancy: perspectives in diagnosis and therapy Peppicelli, Silvia
2014
2-3 p. 823-832
artikel
24 Functional link between plasma membrane spatiotemporal dynamics, cancer biology, and dietary membrane-altering agents Erazo-Oliveras, Alfredo
2018
2-3 p. 519-544
artikel
25 Growth factor and signaling pathways and their relevance to prostate cancer therapeutics Wozney, Jocelyn L.
2014
2-3 p. 581-594
artikel
26 Guest Editor 2003
2-3 p. 125-126
artikel
27 Histone H2A.Z deregulation in prostate cancer. Cause or effect? Dryhurst, Deanna
2014
2-3 p. 429-439
artikel
28 Immune regulation of therapy-resistant niches: emerging targets for improving anticancer drug responses Jinushi, Masahisa
2014
2-3 p. 737-745
artikel
29 Immunotherapy for prostate cancer: recent developments and future challenges Schweizer, Michael T.
2014
2-3 p. 641-655
artikel
30 Immunotherapy for prostate cancer: recent developments and future challenges Schweizer, Michael T.

2-3 p. 641-655
artikel
31 Insulin-like growth factor receptor-1 (IGF-IR) as a target for prostate cancer therapy Wu, Jennifer
2014
2-3 p. 607-617
artikel
32 Integrating new discoveries into the “vicious cycle” paradigm of prostate to bone metastases Cook, Leah M.
2014
2-3 p. 511-525
artikel
33 Lack of effective translational regulation of PLD expression and exosome biogenesis in triple-negative breast cancer cells Gomez-Cambronero, Julian
2018
2-3 p. 491-507
artikel
34 Matrix metalloproteinase inhibitors (MMPIs): The beginning of phase I or the termination of phase III clinical trials Pavlaki, Maria
2003
2-3 p. 177-203
artikel
35 Membrane anchored serine proteases: A rapidly expanding group of cell surface proteolytic enzymes with potential roles in cancer Netzel-Arnett, Sarah
2003
2-3 p. 237-258
artikel
36 Metastatic castration-resistant prostate cancer (CRPC): preclinical and clinical evidence for the sequential use of novel therapeutics Mukherji, Deborah
2014
2-3 p. 555-566
artikel
37 Metastatic castration-resistant prostate cancer (CRPC): preclinical and clinical evidence for the sequential use of novel therapeutics Mukherji, Deborah

2-3 p. 555-566
artikel
38 Mimicking breast cancer-induced bone metastasis in vivo: current transplantation models and advanced humanized strategies Thibaudeau, Laure
2014
2-3 p. 721-735
artikel
39 Mouse models of prostate cancer: picking the best model for the question Grabowska, Magdalena M.
2014
2-3 p. 377-397
artikel
40 mPGES-1 and ALOX5/-15 in tumor-associated macrophages Weigert, Andreas
2018
2-3 p. 317-334
artikel
41 MT1-MMP and MMP-7 in invasion and metastasis of human cancers Shiomi, Takayuki
2003
2-3 p. 145-152
artikel
42 Novel drugs targeting the androgen receptor pathway in prostate cancer Mateo, Joaquin
2014
2-3 p. 567-579
artikel
43 Novel roles of apoptotic caspases in tumor repopulation, epigenetic reprogramming, carcinogenesis, and beyond Zhao, Ruya
2018
2-3 p. 227-236
artikel
44 Omega-3 polyunsaturated fatty acids as adjuvant therapy of colorectal cancer Volpato, Milene
2018
2-3 p. 545-555
artikel
45 Oxygenated lipid signaling in tumor-associated macrophages—focus on colon cancer Colby, Jennifer K.
2018
2-3 p. 289-315
artikel
46 Pericellular cathepsin B and malignant progression Roshy, Stefanie
2003
2-3 p. 271-286
artikel
47 Platelets and extracellular vesicles in cancer: diagnostic and therapeutic implications Dovizio, Melania
2018
2-3 p. 455-467
artikel
48 Preface Heath, Elisabeth I.
2014
2-3 p. 375-376
artikel
49 Preface Gartung, Allison
2018
2-3 p. 201-202
artikel
50 Preface: Membrane-associated proteases Seiki, Motoharu
2003
2-3 p. 127-128
artikel
51 RANK-mediated signaling network and cancer metastasis Chu, Gina Chia-Yi
2014
2-3 p. 497-509
artikel
52 Recent progress on nutraceutical research in prostate cancer Li, Yiwei
2013
2-3 p. 629-640
artikel
53 RECK: A novel suppressor of malignancy linking oncogenic signaling to extracellular matrix remodeling Noda, Makoto
2003
2-3 p. 167-175
artikel
54 Role of autotaxin in cancer stem cells Lee, Dongjun
2018
2-3 p. 509-518
artikel
55 Role of pericellular proteolysis by membrane-type 1 matrix metalloproteinase in cancer invasion and angiogenesis Seiki, Motoharu
2003
2-3 p. 129-143
artikel
56 Role of prostaglandins in tumor microenvironment Kobayashi, Koji
2018
2-3 p. 347-354
artikel
57 Roles of hepatocyte growth factor (HGF) activator and HGF activator inhibitor in the pericellular activation of HGF/scatter factor Kataoka, Hiroaki
2003
2-3 p. 223-236
artikel
58 Roles of prostaglandins in tumor-associated lymphangiogenesis with special reference to breast cancer Lala, Peeyush K.
2018
2-3 p. 369-384
artikel
59 Seprase complexes in cellular invasiveness Chen, Wen-Tien
2003
2-3 p. 259-269
artikel
60 Src signaling pathways in prostate cancer Varkaris, Andreas
2013
2-3 p. 595-606
artikel
61 Stress, inflammation, and eicosanoids: an emerging perspective Umamaheswaran, Sujanitha
2018
2-3 p. 203-211
artikel
62 Targeting cytochrome P450-dependent cancer cell mitochondria: cancer associated CYPs and where to find them Guo, Zhijun
2018
2-3 p. 409-423
artikel
63 Targeting lipid mediators in cancer biology Sulciner, Megan L.
2018
2-3 p. 557-572
artikel
64 Targeting the enzymes involved in arachidonic acid metabolism to improve radiotherapy Kim, Wanyeon
2018
2-3 p. 213-225
artikel
65 The developing story of Sprouty and cancer Masoumi-Moghaddam, Samar
2014
2-3 p. 695-720
artikel
66 The importance of 15-lipoxygenase inhibitors in cancer treatment Orafaie, Ala
2018
2-3 p. 397-408
artikel
67 The lipid products of phosphoinositide 3-kinase isoforms in cancer and thrombosis Anquetil, Typhaine
2018
2-3 p. 477-489
artikel
68 The role of epithelial plasticity in prostate cancer dissemination and treatment resistance Bitting, Rhonda L.
2014
2-3 p. 441-468
artikel
69 The role of lipid signaling in the progression of malignant melanoma Tímár, József
2018
2-3 p. 245-255
artikel
70 The roles of the COX2/PGE2/EP axis in therapeutic resistance Tong, Dali
2018
2-3 p. 355-368
artikel
71 The urokinase plasminogen activator system in cancer: Recent advances and implication for prognosis and therapy Sidenius, Nicolai
2003
2-3 p. 205-222
artikel
72 Thrombospondin-1 interactions regulate eicosanoid metabolism and signaling in cancer-related inflammation Ramirez, Manuel U.
2018
2-3 p. 469-476
artikel
73 Triumph and tumult of matrix metalloproteinases and their crosstalk with eicosanoids in cancer Chatterjee, Kasturi
2018
2-3 p. 279-288
artikel
74 Validation of proposed prostate cancer biomarkers with gene expression data: a long road to travel Amaro, Adriana
2014
2-3 p. 657-671
artikel
                             74 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland